(Q33282924)

25 July 2017

title

Thiazolidinedione induced thyroid associated orbitopathy (English)

1 reference

25 July 2017

Seongmu Lee

1

1 reference

25 July 2017

Angelo Tsirbas

series ordinal

2

1 reference

25 July 2017

Robert A Goldberg

series ordinal

3

1 reference

25 July 2017

John D McCann

series ordinal

4

1 reference

25 July 2017

publication date

26 April 2007

1 reference

25 July 2017

1 reference

25 July 2017

volume

7

1 reference

25 July 2017

page(s)

8

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876204

25 July 2017

1 reference

Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy

21 June 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876204

Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts

21 June 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876204

The epidemiologic characteristics and clinical course of ophthalmopathy associated with autoimmune thyroid disease in Olmsted County, Minnesota

21 June 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876204

Fenofibrate increases the expression of high mobility group AT-hook 2 (HMGA2) gene and induces adipocyte differentiation of orbital fibroblasts from Graves' ophthalmopathy

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-7-8

PPARgamma-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-7-8

Peroxisome proliferator-activated receptor-gamma in thyroid eye disease: contraindication for thiazolidinedione use?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-7-8

Rosiglitazone-induced proptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-7-8

Occurrence of Ophthalmopathy after Treatment for Graves' Hyperthyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-7-8

TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patients

21 January 2018

1 reference

12 December 2020

Peroxisome proliferator-activated receptor-gamma gene expression in orbital adipose/connective tissues is increased during the active stage of Graves' ophthalmopathy

1 reference

12 December 2020

Smoking and thyroid-associated ophthalmopathy: A novel explanation of the biological link

1 reference

12 December 2020

Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy

1 reference

12 December 2020

Treatment with a thiazolidinedione increases eye protrusion in a subgroup of patients with type 2 diabetes.

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2415-7-8

1 reference

Dimensions Publication ID

25 July 2017

0 references

1 reference

25 July 2017

1 reference